One sentence summary: The killing efficiency of ciprofloxacin depends on the specific growth rate of Escherichia coli prior to antibiotic exposure. Editor: Jana Jass
INRODUCTION
Bacterial susceptibility to antibiotics is in many cases strongly affected by their growth phase. Drug tolerance increases with decreasing growth rates and is reduced to a minimum in fast growing cultures (Gilbert, Collier and Brown 1990) . It was shown that in glucose-limited cultures of Escherichia coli, the rate of bacterial killing by several antibiotics is strictly proportional to the specific growth rate of bacteria (Tuomanen et al. 1986) . It has been also demonstrated that both gram-positive and gram-negative bacteria are highly tolerant to antibiotics during non-growing and slow-growth phases (Eng et al. 1991; Sufya, Allison and Gilbert 2003; Maisonneuve, Castro-Camargo and Gerdes 2013) . We have recently reported that for ciprofloxacin and ampicillin treatments, strong inverse correlations exist between the survival [log(CFU ml -1 )] of E. coli strains harboring mutations in genes encoding the components of thiol redox pathways and their specific growth rates prior to antibiotic addition (Smirnova et al. 2016a,b) . Similar correlations are observed when bacteria are pretreated with various compounds and then exposed to the two above-mentioned antibiotics and suboptimal temperatures (Smirnova et al. 2016a,b) . Interestingly, the nature of the factors that affect the bacterial growth rate (e.g. the composition of the medium, physicochemical conditions, additives or mutations) is not relevant for the antibiotic tolerance. It should be noted that various mutations and treatments are often used in studies of the mechanisms determining bacterial tolerance to antibiotics, but their effect on the specific growth rate of bacteria is not taken into account.
In the current study, we investigated the effect of bacterial growth rate on the susceptibility to ciprofloxacin of E. coli. We evaluated mutants deficient in enzymes of the tricarboxylic acid (TCA) cycle grown on glucose, and wild-type cells (wt) grown on various carbon sources. Further, we collated the data from the current and previous studies (Smirnova et al. 2016a (Smirnova et al. ,b, 2017 into a complete dataset, and subjected them to statistical analysis. This allowed us to reveal a quantitative relationship between the killing efficiency of ciprofloxacin and the specific growth rate prior to the addition of antibiotic in a wide range of bacterial growth rates (0.01-1.3 h −1 ).
MATERIALS AND METHODS

Bacterial strains and culture media
The parental strain of E. coli BW25113 (wt) and knockout mutants JW1268 ( acnA), JW3205 ( mdh) and JW0716 ( sucB) used in this study were from the Keio collection (E. coli Genetic Stock Center). Cultures of E. coli wt were grown aerobically at 37
• C in 250-ml flasks with shaking at 150 rpm in M9 minimal medium (Miller 1972 ) supplemented with glucose (1.5 g l −1 ) or acetate, succinate, malate and α-ketoglutarate (20 mM each) as the sole carbon and energy sources. The mutants were grown in M9 minimal medium containing 1.5 g l −1 glucose.
TCA cycle acids, ciprofloxacin and Luria broth (LB) agar were from Sigma Chemical Co. (St. Louis, MO, USA). All other reagents were of analytical grade (Reachim, Moscow, Russia).
Determination of the specific growth rate (μ)
The cells were grown overnight, centrifuged and resuspended in 100 ml of fresh medium to OD 600 = 0.1. They were then grown aerobically as described above. Bacteria were treated with ciprofloxacin in mid-log phase (OD 600 = 0.4), following which the growth was monitored for 2 h. Concentrations of ciprofloxacin used in the experiments were 0.3 μg ml -1 (25 MIC) and 3.0 μg ml -1 (250 MIC). The concentration of 0.3 μg ml -1 corresponds to a value that is close to the optimal bactericidal concentration (OBC) for ciprofloxacin (Lewin, Morrissey and Smith 1991) . The μ value was calculated, as μ = ( lnOD 600 ) t -1 , where t is the time in h and OD 600 is the value determined at time t. OD 600 was determined using a Shimadzu UV-1700 spectrophotometer (Japan).
Analysis of colony-forming units and bacterial killing rate (ψ)
For colony-forming unit (CFU) studies, the cells were grown as above to OD 600 = 0.4. Aliquots (1 ml) were withdrawn prior to, and 30, 60 and 120 min after the antibiotic treatment. The cells were washed and serially diluted in 0.9% NaCl. Each dilution (1 ml) was then mixed with 3 ml of molten soft LB agar (0.8%, at 42
• C) and spread on three Luria broth (LB) agar plates (1.5%) for the viable count determination. All experiments were conducted at least three times on different days. Colonies were counted after a 24-h incubation at 37
• C. The rate of ciprofloxacin-induced bacterial killing (ψ) was calculated based on the decline of the density of viable bacteria over a defined period, using the equation ψ = [ln(N t /N 0 )]t -1 , where N t is the cell density (CFU ml -1 ) at time t; N 0 the initial cell density and t the time in hours (1 in the current study) (Regoes et al. 2004) .
Minimum inhibitory concentration determination
Minimum inhibitory concentration (MIC) values were determined using the microdilution method as outlined in the Clinical and Laboratory Standards Institute (CLSI 2009), except that the M9 minimal medium was used. After 22 h of incubation at 37
• C, the cell density (OD 600 ) in each well of a 96-well plate was measured using the 96-well microplate spectrophotometer xMark (Bio-Rad Laboratories, Inc. USA). The experiments were conducted three times on separate days.
Statistical analysis
The data are presented as the means of at least three independent experiments ± the standard error of the mean. They were analyzed using the program packet Microsoft Excel (Microsoft Office 2003, Microsoft Co., USA) and Statistica 6 (StatSoft Inc. 2001, USA). Significant differences were determined using the Student's t-test. A P-value of 0.05 was used as the cut-off of statistical significance.
RESULTS AND DISCUSSION
Ciprofloxacin susceptibility of E. coli wt grown on different substrates
Similar to other bacteria, E. coli is able to utilize different carbon and energy sources, with the growth rate characteristic for each substrate (Andersen and Meyenburg 1980) . This was also the case in the current study, when wt E. coli was grown in M9 minimal medium containing one of the following substrates: glucose, malate, succinate, α-ketoglutarate or acetate. Under these conditions, the specific bacterial growth rates (μ) were 0.63, 0.5, 0.37, 0.36 and 0.18 h -1 , respectively. Treatment of exponentially growing cultures with ciprofloxacin resulted in a dramatic CFU reduction. Cultures growing on different substrates exhibited markedly different survival following exposure to the antibiotic. After a 60-min exposure to 0.3 μg ml -1 of ciprofloxacin, the number of surviving cells was reduced 560, 110, 74, 62 and 5 times during growth on glucose, succinate, malate, α-ketoglutarate and acetate, respectively (Fig. 1A) . On exposure to 3 μg ml -1 of ciprofloxacin, CFU ml -1 values were reduced 128, 15, 21, 14 and 3 times, respectively (Fig. 1B) . In all cases, the rate at which the bacteria were killed declined with the time of exposure. The killing rates (ψ) calculated for the first hour of exposure to ciprofloxacin are shown in Fig. 1C . The greatest bactericidal effect of ciprofloxacin was observed for E. coli grown on glucose, with the lowest effect observed for acetate-grown cells. Thus, the rate of cell death increased with the increasing culture growth rate prior to the addition of the antibiotic. It is remarkable that cell survival in the presence of ciprofloxacin increased by two orders of magnitude when the growth rate decreased 3.5 times.
It should be noted that the rates of E. coli killing by ciprofloxacin for bacteria grown on all substrates were higher for the 0.3 μg ml -1 dose than for the 3.0 μg ml -1 dose of this antibiotic (Fig. 1C) . This paradoxical effect of ciprofloxacin and other quinolones was previously reported for bacteria grown in the nutrient broth and was presumably associated with the inhibition of RNA synthesis at concentrations above OBC ( is blocked by a deficiency of the Lon protease (Malik, Capecci and Drlica 2009 ) and is not observed in the recA mutant, where the degree of CFU reduction by the antibiotic is proportional to ciprofloxacin concentration (Smirnova et al. 2017) .
Effect of the TCA cycle mutations on ciprofloxacin susceptibility
It has been previously shown that some mutants of E. coli deficient in the TCA cycle enzymes are more tolerant to the quinolones nalidixic acid and norfloxacin than the parental strains (Helling and Kukora 1971; Gruer, Bradbury and Guest 1997; Kohanski et al. 2007 ). Hence, we tested the relationship between ciprofloxacin susceptibility and growth rate of such E. coli mutants. We used isogenic knockout mutants of E. coli deficient in the following TCA cycle enzymes: aconitase (JW1268, acnA), malate dehydrogenase (JW3205, mdh) and 2-oxoglutarate dehydrogenase (JW0716, sucB). For all the studied strains, the MIC values for ciprofloxacin were 0.012 μg ml -1 when the bacteria were grown in M9 minimal medium with glucose.
In glucose-containing minimal medium, the specific growth rates of the acnA, mdh and sucB mutants were 0.57, 0.55 and 0.36 h -1 , respectively. Thus, the acnA and mdh mutations resulted in a moderate growth rate reduction, while the growth rate of sucB decreased to 57% of that of the parental strain. It was previously reported that the susceptibility to norfloxacin of E. coli acnA, mdh and sucB mutants grown on rich LB medium does not differ significantly from that of the parental strain MG1655 (Kohanski et al. 2007 ). Under the conditions tested in the current study, no significant differences in the effect of ciprofloxacin on the survival of the parental strain and mutants lacking acnA or mdh were apparent (P = 0.061 and P = 0.97 at 0.3 μg ml -1 of ciprofloxacin for acnA and mdh strains, respectively; P = 0.471 and P = 0.101 at 3 μg ml -1 of ciprofloxacin for acnA and mdh strains, respectively) ( Fig. 2A and B) . However, the rate of killing of the slowly growing sucB mutant was 1.5 and 1.6 times lower, and the survival was 7.4 and 6 times higher than that of the parent strain at low and high doses of ciprofloxacin, respectively (Fig. 2) . Statistical analysis of the data from the two sets of experiments described above (Figs 1 and 2 ) revealed significant inverse correlations between log(CFU ml -1 ) value following 0.3 and 3.0 μg ml -1 of ciprofloxacin exposure, and the specific growth rate prior to the antibiotic treatment (r = −0.93 and −0.96, respectively; Fig. S1A and B, Supporting Information). It is remarkable that an increase in the growth rate (μ) by 0.1 h -1 led to an increase in the ciprofloxacin-induced killing rate (ψ) by about 1 h -1 (Fig. S1C and D, Supporting Information).
Collation of our current and previous data on the relationship between the growth rate and ciprofloxacin susceptibility
Results similar to the above data were obtained previously for E. coli strains grown aerobically in the M9 minimal medium with glucose at different growth temperatures after treatment with 3.0 μg ml -1 of ciprofloxacin (Smirnova et al. 2016b) . Eight of 11 strains tested therein were single and double mutants lacking the components of the glutathione and thioredoxin redox systems. The tested strains also included relA, rpoS and oxyR mutants defective in the stringent response, and the global regulators σ S and OxyR, respectively. The growth rates before antibiotic addition varied from 0.02 to 0.73 h -1 , while CFU ml -1 in the ciprofloxacin-treated cultures ranged from 2 to 1820 × 10 5 ml -1 (Table S1 , Supporting Information). A strong inverse correlation between the cellular sensitivity to ciprofloxacin determined 2 h after treatment [log(CFU ml -1 )] and the specific growth rate prior to the drug addition (r = -0.96) was found.
In another published study, we examined the relationship between the growth rate and the ciprofloxacin sensitivity of E. coli pretreated with different compounds that affect the cellular redox state (Smirnova et al. 2016a) . The parental (BW25113) and gshA mutant (JW2663) strains were grown aerobically at 37
• C in the M9 minimal glucose medium or LB medium. The cells were pretreated with reduced and oxidized glutathione, cysteine, cystine, SH-reagent N-ethylmaleimide or valine. The pretreatments exerted a constant or transient effect on the bacterial growth Figure 3 . Inverse correlation between log(CFU ml -1 ) 1 h after ciprofloxacin (3 μg ml -1 ) addition and the specific growth rate of E. coli prior to antibiotic exposure. The source data are presented in Figs 1B and 2B, and in previously published papers (Smirnova et al. 2016a (Smirnova et al. ,b, 2017 rates, which varied in the maximum possible range from 0.01 to 1.3 h −1 . After the addition of 3.0 μg ml -1 of ciprofloxacin to the pretreated cells, CFU ml -1 varied from 0.4 to 873 × 10 5 ml -1 (Table S2 , Supporting Information). Statistical analysis revealed a strong inverse correlation between the growth rate prior to the antibiotic addition and bacterial survival following the treatment of the parental strain and gshA mutant with ciprofloxacin (r = -0.98 and -0.94, respectively).
Since the data reported in the current (Figs 1 and 2 ) and in previous (Smirnova et al. 2016a,b) studies were obtained in the same laboratory using isogenic E. coli strains, we performed a correlation analysis for the data from all the above-mentioned experiments for the bacterial treatment with 3.0 μg ml -1 of ciprofloxacin. We also included previously published data on the recA knockout strain (E. coli JW2669) (Smirnova et al. 2017) . Under these experimental conditions, the treatment of JW2669 with 3.0 μg ml -1 of ciprofloxacin resulted in log(CFU ml -1 ) reduction to 1.81 within 2 h of exposure; in the parental strain, this value decreased to 5.56. The specific growth rate of JW2669 before drug addition was close to that of the parental strain (Table S3 , Supporting Information). These results were consistent with the previously published observations on the high sensitivity of recA mutants to bactericidal antibiotics (Kohanski et al. 2007) . As expected, statistical analysis of the complete datasets from all experiments (except for the recA mutant) confirmed the existence of significant inverse correlations between the bacterial specific growth rate before ciprofloxacin (3.0 μg ml -1 ) addition and log(CFU ml -1 ) after exposure to the antibiotic for 1 h (r = -0.92) (Fig. 3 ) and 2 h (r = -0.86). When the recA mutant was included in the correlation analysis, these values were -0.84 and -0.82, respectively. As shown in Fig. 3 , under the experimental conditions used, a two-fold decrease in the specific growth rate compared to μ max increased the ciprofloxacin tolerance of E. coli by two orders of magnitude. Ciprofloxacin kills bacteria by damaging their DNA by interacting with specific intracellular targets, gyrase and topoisomerase IV (Drlica et al. 2008) . DNA damage activates the SOS gene network, which leads to the production of various repair proteins. RecA and LexA proteins play a major role in the regulation of the SOS response induced by ciprofloxacin (Cirz et al. 2005) . In Fig. 3 , the data point corresponding to the recA mutant lies well below the correlation line, which reflects the high sensitivity of the mutant to ciprofloxacin and is associated with the specific mode of action of the drug.
The data presented herein are in agreement with earlier observations that, in many cases, antibiotic sensitivity is strongly influenced by the bacterial growth rate. Notably, in the current and previous studies, the factors that determined the growth rates were very different: the flow rate in the chemostat; composition of the culture medium; pretreatment with various reagents; growth temperature and mutations (Tuomanen et al. 1986; Eng et al. 1991; Sufya, Allison and Gilbert 2003; Maisonneuve, Castro-Camargo and Gerdes 2013; Smirnova et al. 2016b) . These factors are largely not directly associated with the known mechanisms of antibiotic tolerance.
The ability of antibiotics to kill the cell or inhibit its growth is usually studied in bacterial cultures growing in media that are supplemented with nutrients, to achieve optimal growth, or in non-growing stationary cultures. In the natural habitat and in a clinical setting, the environmental parameters may be less optimal and, accordingly, the bacteria might exhibit different growth rates (Gilbert, Collier and Brown 1990 ). In the current study, we investigated the susceptibility of bacteria to ciprofloxacin over a wide range of growth rates (from near 0 to the maximum possible values for aerobic cultures). As shown in Fig. 3 , even slight changes in the growth rate led to marked variations in the bactericidal effect of the antibiotic. Mutants and various inhibitors are widely used in investigations of the antibacterial action of antibiotics. The data presented in the current study suggest that the effect on growth rate must be accounted for in such cases. Some mutants with a reduced growth rate and supplements that affect bacterial growth may not be suitable for studying the mechanisms of antibiotic action. Pharmacodynamic data obtained herein, i.e. the growth or death rates of target bacteria (Regoes et al. 2004) , may be used in a rational design of effective antibiotic treatment protocols.
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